Chronic renal dysfunction late after liver transplantation

Ari J. Cohen, Mark D Stegall, Charles B. Rosen, Russell H. Wiesner, Nelson Leung, Walter K Kremers, Nizar N. Zein

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

With the increasing success of liver transplantation, more patients are developing late complications such as renal dysfunction. The goal of the current study was to assess the prevalence of renal dysfunction years after liver transplantation and to identify patients at risk for the development of this complication. Of the 527 liver transplantations performed at our institution between April 1990 and October 1998, 353 had pretransplantation and posttransplantation glomerular filtration rate (GFR) determinations by iothalamate clearance. From this entire group, 198 patients had actual 4-year follow-up and 52 had actual 6-year follow-up. In addition, 191 of these patients had intensive follow-up with GFR measurements pretransplantation and at 1 and 3 years posttransplantation (complete follow-up group). All patients received either tacrolimus- or cyclosporine-based immunosuppression. The overall mean GFR levels in both of these groups was acceptable and was not different in cyclosporine- versus tacrolimus-based immunosuppressive regimens. Renal dysfunction was progressive, with 27.5% of patients in the intensive group having a GFR < 40 mL/min/body surface area 5 years after transplantation. GFR pretransplantation did not correlate well with late renal function; however, GFR at 1 year identified patients with subsequent renal dysfunction. The cumulative incidence of renal failure for the entire group was 6.25% at 7 years and 10% at 10 years. Renal dysfunction is a major late complication after liver transplantation. The GFR at 1 year correlates best with late renal function. Patients with a low GFR at 1 year (< 40 mL/min/BSA) are a high-risk group that might benefit from early therapeutic interventions aimed at preventing subsequent renal failure.

Original languageEnglish (US)
Pages (from-to)916-921
Number of pages6
JournalLiver Transplantation
Volume8
Issue number10
DOIs
StatePublished - Oct 1 2002

Fingerprint

Glomerular Filtration Rate
Liver Transplantation
Kidney
Tacrolimus
Cyclosporine
Renal Insufficiency
Iothalamic Acid
Body Surface Area
Immunosuppressive Agents
Immunosuppression
Transplantation
Incidence

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Chronic renal dysfunction late after liver transplantation. / Cohen, Ari J.; Stegall, Mark D; Rosen, Charles B.; Wiesner, Russell H.; Leung, Nelson; Kremers, Walter K; Zein, Nizar N.

In: Liver Transplantation, Vol. 8, No. 10, 01.10.2002, p. 916-921.

Research output: Contribution to journalArticle

Cohen, AJ, Stegall, MD, Rosen, CB, Wiesner, RH, Leung, N, Kremers, WK & Zein, NN 2002, 'Chronic renal dysfunction late after liver transplantation', Liver Transplantation, vol. 8, no. 10, pp. 916-921. https://doi.org/10.1053/jlts.2002.35668
Cohen, Ari J. ; Stegall, Mark D ; Rosen, Charles B. ; Wiesner, Russell H. ; Leung, Nelson ; Kremers, Walter K ; Zein, Nizar N. / Chronic renal dysfunction late after liver transplantation. In: Liver Transplantation. 2002 ; Vol. 8, No. 10. pp. 916-921.
@article{46eba8af580c49dd8125f1cf332c4436,
title = "Chronic renal dysfunction late after liver transplantation",
abstract = "With the increasing success of liver transplantation, more patients are developing late complications such as renal dysfunction. The goal of the current study was to assess the prevalence of renal dysfunction years after liver transplantation and to identify patients at risk for the development of this complication. Of the 527 liver transplantations performed at our institution between April 1990 and October 1998, 353 had pretransplantation and posttransplantation glomerular filtration rate (GFR) determinations by iothalamate clearance. From this entire group, 198 patients had actual 4-year follow-up and 52 had actual 6-year follow-up. In addition, 191 of these patients had intensive follow-up with GFR measurements pretransplantation and at 1 and 3 years posttransplantation (complete follow-up group). All patients received either tacrolimus- or cyclosporine-based immunosuppression. The overall mean GFR levels in both of these groups was acceptable and was not different in cyclosporine- versus tacrolimus-based immunosuppressive regimens. Renal dysfunction was progressive, with 27.5{\%} of patients in the intensive group having a GFR < 40 mL/min/body surface area 5 years after transplantation. GFR pretransplantation did not correlate well with late renal function; however, GFR at 1 year identified patients with subsequent renal dysfunction. The cumulative incidence of renal failure for the entire group was 6.25{\%} at 7 years and 10{\%} at 10 years. Renal dysfunction is a major late complication after liver transplantation. The GFR at 1 year correlates best with late renal function. Patients with a low GFR at 1 year (< 40 mL/min/BSA) are a high-risk group that might benefit from early therapeutic interventions aimed at preventing subsequent renal failure.",
author = "Cohen, {Ari J.} and Stegall, {Mark D} and Rosen, {Charles B.} and Wiesner, {Russell H.} and Nelson Leung and Kremers, {Walter K} and Zein, {Nizar N.}",
year = "2002",
month = "10",
day = "1",
doi = "10.1053/jlts.2002.35668",
language = "English (US)",
volume = "8",
pages = "916--921",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Chronic renal dysfunction late after liver transplantation

AU - Cohen, Ari J.

AU - Stegall, Mark D

AU - Rosen, Charles B.

AU - Wiesner, Russell H.

AU - Leung, Nelson

AU - Kremers, Walter K

AU - Zein, Nizar N.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - With the increasing success of liver transplantation, more patients are developing late complications such as renal dysfunction. The goal of the current study was to assess the prevalence of renal dysfunction years after liver transplantation and to identify patients at risk for the development of this complication. Of the 527 liver transplantations performed at our institution between April 1990 and October 1998, 353 had pretransplantation and posttransplantation glomerular filtration rate (GFR) determinations by iothalamate clearance. From this entire group, 198 patients had actual 4-year follow-up and 52 had actual 6-year follow-up. In addition, 191 of these patients had intensive follow-up with GFR measurements pretransplantation and at 1 and 3 years posttransplantation (complete follow-up group). All patients received either tacrolimus- or cyclosporine-based immunosuppression. The overall mean GFR levels in both of these groups was acceptable and was not different in cyclosporine- versus tacrolimus-based immunosuppressive regimens. Renal dysfunction was progressive, with 27.5% of patients in the intensive group having a GFR < 40 mL/min/body surface area 5 years after transplantation. GFR pretransplantation did not correlate well with late renal function; however, GFR at 1 year identified patients with subsequent renal dysfunction. The cumulative incidence of renal failure for the entire group was 6.25% at 7 years and 10% at 10 years. Renal dysfunction is a major late complication after liver transplantation. The GFR at 1 year correlates best with late renal function. Patients with a low GFR at 1 year (< 40 mL/min/BSA) are a high-risk group that might benefit from early therapeutic interventions aimed at preventing subsequent renal failure.

AB - With the increasing success of liver transplantation, more patients are developing late complications such as renal dysfunction. The goal of the current study was to assess the prevalence of renal dysfunction years after liver transplantation and to identify patients at risk for the development of this complication. Of the 527 liver transplantations performed at our institution between April 1990 and October 1998, 353 had pretransplantation and posttransplantation glomerular filtration rate (GFR) determinations by iothalamate clearance. From this entire group, 198 patients had actual 4-year follow-up and 52 had actual 6-year follow-up. In addition, 191 of these patients had intensive follow-up with GFR measurements pretransplantation and at 1 and 3 years posttransplantation (complete follow-up group). All patients received either tacrolimus- or cyclosporine-based immunosuppression. The overall mean GFR levels in both of these groups was acceptable and was not different in cyclosporine- versus tacrolimus-based immunosuppressive regimens. Renal dysfunction was progressive, with 27.5% of patients in the intensive group having a GFR < 40 mL/min/body surface area 5 years after transplantation. GFR pretransplantation did not correlate well with late renal function; however, GFR at 1 year identified patients with subsequent renal dysfunction. The cumulative incidence of renal failure for the entire group was 6.25% at 7 years and 10% at 10 years. Renal dysfunction is a major late complication after liver transplantation. The GFR at 1 year correlates best with late renal function. Patients with a low GFR at 1 year (< 40 mL/min/BSA) are a high-risk group that might benefit from early therapeutic interventions aimed at preventing subsequent renal failure.

UR - http://www.scopus.com/inward/record.url?scp=0036794560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036794560&partnerID=8YFLogxK

U2 - 10.1053/jlts.2002.35668

DO - 10.1053/jlts.2002.35668

M3 - Article

C2 - 12360433

AN - SCOPUS:0036794560

VL - 8

SP - 916

EP - 921

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 10

ER -